From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza. [PDF]
Sun Y +4 more
europepmc +1 more source
Detection and characterization of antiviral-resistant viruses during the influenza season of 2024-25. [PDF]
Patel MC +19 more
europepmc +1 more source
Effectiveness of baloxavir marboxil in nonhuman primates infected with highly pathogenic avian influenza A(H7N9) virus. [PDF]
Iwatsuki-Horimoto K +8 more
europepmc +1 more source
Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015-2022 Influenza Seasons. [PDF]
Lee K, Basu A, Englund JA.
europepmc +1 more source
Signal mining of adverse reactions for neuraminidase inhibitors in pregnant women: a disproportionality analysis based on the FDA adverse event reporting system database. [PDF]
Cao B, Shen M, Du C, Song Q, Ma Z.
europepmc +1 more source
Antiviral Resistance in Influenza: Clinical and Public Health Implications. [PDF]
Ngiam JN, Koh MCY, Hayden FG.
europepmc +1 more source
ShinyVar: a web-based application for comparative Influenza variant analysis supporting structure-guided approaches to vaccine and antiviral drug design. [PDF]
Lee D, Sangket U.
europepmc +1 more source
Influenza A in the Perioperative Setting of Liver Transplantation. [PDF]
Vlachos DK +5 more
europepmc +1 more source
ICU admission and mortality in adult patients with influenza A(H1N1)pdm09-related pneumonia in Vietnam since the 2009 H1N1 pandemic: A 10-year cohort study. [PDF]
Ho QM +12 more
europepmc +1 more source

